Aaron Kesselheim: key facts
- Kind of voice
- Academic
- Role
- Harvard Medical School researcher
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 30 Sept 2026
“Harvard Medical School researchers Benjamin Rome and Aaron Kesselheim, who have published repeatedly on this question, have argued that expanding the exemption would unnecessarily limit the number of eligible drugs while allowing continued high prices for products earning billions in Medicare.”
Where Aaron Kesselheim has been quoted
- Exempting Rare Disease Drugs Would Erase Most Savings from a Medicare Price Pilot, Analysis Findsmedicaldaily.com · 30 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.